Surgery Partners Financial Statements
NASDAQ: SGRYHealth CareHospital/Nursing ManagementUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Surgery Partners revenue and earnings
In fiscal 2025, Surgery Partners generated $3.31 billion in revenue, up 6.2% from fiscal 2024, its 11th consecutive year of revenue growth. Surgery Partners reported a net loss of $77.9 million, compared with a loss of $168.1 million a year earlier. Operating margin was 11.8%.
Diluted earnings per share came in at -$0.61. Over the last 5 fiscal years, SGRY's revenue has grown at a 12.2% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Surgery Partners income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20162016-12-31 | FY 20152015-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.31B | 3.11B | 2.74B | 2.54B | 2.23B | 1.86B | 1.83B | 1.77B | 1.15B | 959.89M |
| Revenue growth (YoY) | +6.24% | +13.52% | +8.03% | +14.12% | +19.62% | +1.57% | +3.38% | +54.66% | +19.33% | +138.02% |
| Cost of Revenue | — | — | — | — | — | — | 1.41B | 1.36B | 821.20M | 669.33M |
| Gross Profit | — | — | — | — | — | — | 423.80M | 410.10M | 324.24M | 290.56M |
| Operating Expenses | 2.92B | 2.77B | 2.42B | 2.19B | 1.92B | 1.68B | 1.60B | 1.69B | 948.96M | 815.14M |
| Operating Income | 389.50M | 348.80M | 328.00M | 345.20M | 302.20M | 183.00M | 235.90M | 77.80M | 196.48M | 144.75M |
| Other Income (Expense) | — | — | 8.60M | 1.50M | -200.00K | — | — | — | — | — |
| Pretax Income | 116.90M | 147.10M | 135.00M | 110.30M | 81.20M | -18.80M | 54.60M | -69.20M | 92.18M | -76.14M |
| Income Tax | 18.00M | 134.60M | -300.00K | 23.30M | 10.50M | -20.10M | 9.50M | 26.40M | 7.09M | -148.98M |
| Net Income | -77.90M | -168.10M | -11.90M | -54.60M | -70.90M | -116.10M | -74.80M | -205.70M | 9.45M | 1.43M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | -2276.03% | +561.51% | — |
| EPS (Basic) | -0.61 | -1.33 | -0.09 | -0.59 | -1.12 | -3.19 | -2.29 | -4.96 | 0.20 | 0.04 |
| EPS (Diluted) | -0.61 | -1.33 | -0.09 | -0.59 | -1.12 | -3.19 | -2.29 | -4.96 | 0.20 | 0.04 |
| Shares Outstanding (Basic) | 127.21M | 126.12M | 125.61M | 91.95M | 72.43M | 48.78M | 48.28M | 48.03M | 48.02M | 36.07M |
| Shares Outstanding (Diluted) | 127.21M | 126.12M | 125.61M | 91.95M | 72.43M | 48.78M | 48.28M | 48.03M | 48.19M | 37.46M |
| EBITDA | 565.50M | 501.40M | 446.10M | 460.00M | 401.00M | 277.80M | 312.40M | 145.20M | 236.03M | 179.30M |
| Gross Margin | — | — | — | — | — | — | 23.14% | 23.15% | 28.31% | 30.27% |
| Operating Margin | 11.77% | 11.20% | 11.96% | 13.59% | 13.58% | 9.84% | 12.88% | 4.39% | 17.15% | 15.08% |
| Net Margin | -2.35% | -5.40% | -43.00% | -2.15% | -3.19% | -6.24% | -4.08% | -11.61% | 83.00% | 15.00% |
This table shows 10 annual periods of Surgery Partners's income statement, from FY 2025 back to FY 2015, across 17 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow SGRY's reporting calendar. What is a income statement?